Acadia Pharmaceuticals Inc. (ACAD) at a glance

Acadia Pharmaceuticals Inc. (ACAD) is a mid-cap Healthcare company. It trades at $27.55, with a P/E of 9.7, a 34.3% profit margin and revenue growth of 9.7%. It does not pay a dividend. Vestovix scores it 59/100 overall. Its strongest dimension is Value (99/100) and its weakest is Growth (33/100). Its volatility is roughly in line with the market.

Price

$27.55

Market cap

$3.61B

P/E ratio

9.7

Dividend yield

None

Beta

0.83

52-week range

$19.69 to $30.96